Methylation of somatostatin receptor 2 gene in neuroendocrine tumours as a predictor of tumour response to peptide receptor radionuclide therapy
Shamus Butt, Joanne Evans, Francesco Mauri and Rohini Sharma
DOI: https://doi.org/10.7861/clinmedicine.19-2-s123
Clin Med March 2019 Shamus Butt
AUniversity of Bristol, Bristol, UK
Joanne Evans
BSurgery and Cancer, Imperial College London, London, UK
Francesco Mauri
BSurgery and Cancer, Imperial College London, London, UK
Rohini Sharma
BSurgery and Cancer, Imperial College London, London, UK
Article Information
vol. 19 no. Suppl 2 123
Published By:
Print ISSN:
Online ISSN:
History:
- Published online May 30, 2019.
Copyright & Usage:
© Royal College of Physicians 2019. All rights reserved.
Author Information
Article usage
Article Tools
Methylation of somatostatin receptor 2 gene in neuroendocrine tumours as a predictor of tumour response to peptide receptor radionuclide therapy
Shamus Butt, Joanne Evans, Francesco Mauri, Rohini Sharma
Clinical Medicine Mar 2019, 19 (Suppl 2) 123; DOI: 10.7861/clinmedicine.19-2-s123
Citation Manager Formats
Related Articles
- No related articles found.
Cited By...
- No citing articles found.